SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing significant price declines driven by recent GameStop liquidations and continuous ETF outflows, intensifying community discussions around its controversial origins and potential for further downside, especially with MicroStrategy's substantial unrealized losses under scrutiny. Bulls, however, are eyeing key support levels, anticipating a rebound.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amid a broad crypto market downturn, prompting widespread losses and panic selling, while many community members are advocating to "buy the dip" in anticipation of future regulatory clarity and increasing utility.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as a major hyperscaler's significantly increased capital expenditure forecast for AI infrastructure sparks investor optimism, counterbalancing recent sector-wide sell-offs attributed by many to market manipulation and concerns over H200 chip sales to China. The community is actively debating whether this presents a dip-buying opportunity, underscoring NVIDIA's pivotal role in the advancing AI revolution amidst shifting narratives.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is actively discussed after reporting strong earnings, fueled by significant cloud and AI growth, which is contrasted by an unexpectedly large 2026 capital expenditure forecast that has the community debating whether it signals confident AI leadership or aggressive overspending.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending after exceeding Q4 earnings expectations with a record positive net income and announcing a $500 million stock buyback. While many anticipate a significant rally from current oversold levels, community discussions also highlight ongoing concerns regarding CEO Evan Spiegel's leadership and the company's high stock-based compensation.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

Kelly Services Class B shares are experiencing extreme volatility and trading halts following the acquisition of Softworld. This news, combined with the stock's low float and high borrow fees, has ignited community speculation about a potential short squeeze, reminiscent of other B-class shares.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Alvotech is actively discussed after securing European approval for its AVT03 biosimilar for bone diseases, with the community highlighting its strengthening biosimilar pipeline and strategic partnerships. This development reinforces optimism for its commercial execution and future regulatory milestones in the expanding sector.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending after securing conditional approval for a U.S. bank charter, fueling community discussions about its significant expansion potential and competitive edge against rivals like SOFI, despite some expressing frustration over its perceived slow price action amidst strong fundamentals.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending due to widespread community discussion amplified by recent reports linking Elon Musk to the Epstein files, intensifying debates around its declining sales, high valuation, and the viability of future ventures like Robotaxi and Optimus.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending amid accusations of significant market manipulation by large entities, causing sharp overnight price drops that clash with underlying narratives of increasing industrial demand and geopolitical hedging. This has spurred a divided community, with many viewing the declines as opportunities to buy into a perceived physical shortage, while others anticipate further volatility and downward pressure.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LXRX Don&#39;t forget the offer price for the diluting shares is $1.30, while the Series B Preferred share is $65.00, which can be converted to 50 shares or equivalent to $1.30 as well. So, they (LXRX) really don&#39;t need this money, or can go along to finish P3 trial for LX9211. 
 
I am going to say this again, there will be no LT negative impact on SP from this dilution as long as 1) Viatris sales ramp, 2) HCM readout positive, 3) LX9211 P3 tested positive, 4) LX9851 tested positive thru P1, P2 &amp; P3. 
 
Zynquista for T1DM would be a bonus, but it also might hurt us again with another CRL. 
 
We almost hit $1.80 after 2-day&#39;s run last month. I predict we will see those prices again soon, and some more ....

Marta K.

Tiago Rebocho

William Wood

Greenest

Craig

Manuel Garcìa

FaithYZ1

Afroze Mohammed

StockTwits Web

Lexicon Pharmaceuticals Inc

 Don't forget the offer price for the diluting shares is $1.30, while the Series B Preferred share is $65.00, which can be converted to 50 shares or equivalent to $1.30 as well. So, they (LXRX) really don't need this money, or can go along to finish P3 trial for LX9211. 
 
I am going to say this again, there will be no LT negative impact on SP from this dilution as long as 1) Viatris sales ramp, 2) HCM readout positive, 3) LX9211 P3 tested positive, 4) LX9851 tested positive thru P1, P2 & P3. 
 
Zynquista for T1DM would be a bonus, but it also might hurt us again with another CRL. 
 
We almost hit $1.80 after 2-day's run last month. I predict we will see those prices again soon, and some more ....

Wyane

@gucag006 I&#39;m with you on Zynquista. I just have a feeling there must be some bad blood between that section at the FDA and LX mgmt. Things never added up last time when mgmt said at least once, and I think it was twice, before the last decision that it had been assured by the staff that all of the information needed for a decision was in order. Then, virtually the first words out of the moderator&#39;s mouth were that needed data on the side effects wasn&#39;t submitted. I knew then we were going to have a bad day. 
The only hope I see is signing on a partner to front the next submission that has a better relationship with the staff. (And no AdCom!)

 I'm with you on Zynquista. I just have a feeling there must be some bad blood between that section at the FDA and LX mgmt. Things never added up last time when mgmt said at least once, and I think it was twice, before the last decision that it had been assured by the staff that all of the information needed for a decision was in order. Then, virtually the first words out of the moderator's mouth were that needed data on the side effects wasn't submitted. I knew then we were going to have a bad day. 
The only hope I see is signing on a partner to front the next submission that has a better relationship with the staff. (And no AdCom!)